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Rb. Prior to entry into S phase, Rb becomes highly phos-
phorylated by cyclin-dependent kinases. This renders
Rb incapable of binding to E2F-1 and may allowreleasedSummary
E2F-1 to activate gene expression (Weinberg, 1995).
Further evidence that E2Fs promote entry into SphaseMembers of the E2F transcription factor family (E2F-
derives from study of Drosophila lacking E2F function1±E2F-5) are believed to be critical positive regulators
in which cell proliferation was arrested in the G1 phaseof cell cycle progression in eukaryotes although the
of thecell cycle after theseventeenth embryonic divisionin vivo functions of the individual E2Fs have not been
(Duronio et al., 1995). In addition, overexpression ofelucidated. Mice were generated that lack E2F-1 and,
E2F-1 in mammalian cellscan causeoncogenesis (John-surprisingly, these mice develop and reproduce nor-
son et al., 1994; Xu et al., 1995; Yang and Sladek, 1995)mally. However, E2F-12/2 mice exhibit a defect in T
and was found to be sufficient to drive serum-starved,lymphocyte development leading to an excess of ma-
growth-arrested fibroblasts into the cell cycle andture T cells due to a maturation stage-specific defect
through S phase (Johnson et al., 1993; Qin et al., 1994).in thymocyte apoptosis. As E2F-12/2 mice age they
Together, these findings suggested that the primary
exhibit a second phenotype marked by aberrant cell
function of E2F-1 might be to activate genes that pro-
proliferation. These findings suggest that while certain
mote the G1 to S phase transition during cell prolifer-
members of the E2F family may positively regulate cell
ation.
cycle progression, E2F-1 functions to regulate apop- However, several recent studies indicate that E2F-1
tosis and to suppress cell proliferation. may have functions in addition to promoting entry into S
phase. One of these may involve regulation of apoptosis.
Introduction The overexpression of E2F-1 or mutated forms of
E2F-1 in serum-starved or actively growing fibroblasts
Normal growth and development involve competing pro- can trigger apoptosis (Qin et al., 1994; Shan and Lee,
cesses of cell proliferation and apoptotic cell death. 1994; Wu and Levine, 1994; Kowalik et al., 1995; Krek et
Transcription factors of the E2F family, comprised of al., 1995) raising the possibility that E2F-1 may regulate
E2F-1±E2F-5, have been suggested to play a key role genes important for cell death. Another possible func-
in the regulation of cell proliferation (La Thangue, 1994; tion is suggested by the observation that Rb-bound
Adams and Kaelin, 1995; Weinberg, 1995). First, E2F E2F-1 can still interact with its cognate DNA sequence
binding sites are crucial for transcriptional activation element and thus repress the transcription of certain
of genes that regulate S phase entryÐsuch as c-myc cell cycle regulatory genes (Bandara et al., 1991; Chel-
(Hiebertet al., 1989; Huang and Hearing, 1989; Thalmeier lappan et al., 1991; Chittenden et al., 1991; Weintraub
et al., 1989), cyclin D (Motokura and Arnold, 1993; Sala et al., 1992, 1995; Neuman et al., 1995; Sellers et al.,
et al., 1994), and cyclin E (DeGregori et al., 1995; Duronio 1995). This finding has prompted the hypothesis that,
and O'Farrell, 1995)Ðand genes that function to engage by repressing transcription, the Rb/E2F-1 complex may
DNA synthesisÐsuch as dihydrofolate reductase (Blake play an active role in suppressing progression through
and Azizkhan, 1989; Mudryj et al., 1990), thymidine ki- G1 until an appropriate signal triggers Rb phosphoryla-
nase (Dou et al., 1992; Ogris et al., 1993), and DNA tion and its release from E2F (Sellers et al., 1995).
polymerase a (Pearson et al., 1991; Sala et al., 1994; Despite considerable progress in elucidating the mul-
DeGregori et al., 1995). Second, the activity of E2Fs as tiple potential functions of E2F-1 during cell prolifera-
transcription factors is regulated by their interaction tion, a potential limitation of the studies so far is their
with other components of the cell cycle machineryÐ use of overexpression of wild-type or mutant versions
of E2F-1 under conditions where wild-type E2F-1 was
present and functional. Thus, it is uncertain whether the7 Present address: Department of Genetics, University of the Basque
Country, Bilbao 48080, Spain. predominant function of E2F-1 is to promote entry into
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Figure 1. Mutation of the E2F-1 Gene
(A) Partial structure of the E2F-1 gene deter-
mined from restriction mapping, Southern hy-
bridization, and DNA sequencing (data not
shown). Exons are depicted as open boxes.
The E2F-1 gene replacement construct is de-
rived from a 7.4 kb fragment of the E2F-1
gene disrupted in exon 3 by the PGK-neo
selectable marker. In addition, exon 4 is de-
leted. Adjacent to the E2F-1 DNA is the nega-
tive selectable marker (PGK HSV-TK). Re-
striction enzyme recognition sites are
abbreviated as follows: E, EcoRV; S, SacI;
Sm, SmaI; X, XcmI; H, HindIII; C, ClaI.
(B) Southern hybridization demonstrates the
presence of the targeted E2F-1 mutation in
mice. Mouse genomic DNA was digested with
the restriction enzyme EcoRV, and analyzed
by Southern blotting using an E2F-1 genomic
probe (as depicted in [A]). The wild-type
E2F-1 gene yields a band of 3.0 kb, while the
mutant gene yields a band of 2.3 kb. Southern
hybridization using other restriction enzymes
and both 59 and 39 E2F-1 genomic probes
demonstrates that the structure of the mutant
gene is as expected in mice derived from all
three ES cell lines (data not shown). Further,
these data and the use of a probe for neo
sequences indicate that additional copies of
the gene targeting construct do not exist
elsewhere in the genome (data not shown).
(C) Northern hybridization demonstrates that
the homozygous E2F-1 mutation abolishes
E2F-1 mRNA expression. RNA was harvested
from cells arrested in S phase from two wild-
type and two E2F-12/2 mice and used for
Northern hybridization with a probe derived
from the 39 coding region of the human
E2F-1 cDNA (see Experimental Procedures).
As shown, wild-type fibroblasts express an
z3.0 kb message corresponding to the
E2F-1 mRNA. This mRNA is not present in
the E2F-1 homozygous mutant fibroblasts. The integrity and amount of RNA in each lane was demonstrated by stripping and rehybridizing
the same blot with a probe specific for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA.
S phase, suppress G1 progression, and/or regulate mutations abolish the ability of E2F-1 to bind DNA, acti-
vate transcription, drive cell cycle progression, or triggerapoptosis. To address this issue, we generated and
studied E2F-1 deficient mice. Although these mice were apoptosis (Helin et al., 1992; Kaelin et al., 1992; Cress
et al., 1993; Johnson et al., 1993; Shan and Lee, 1994).found to develop and reproduce normally, they exhibited
a number of defects in T cell development indicating The E2F-1 targeting construct also deletes E2F-1 exon
4, encoding the leucine zipper and part of a ªmarkedthat E2F-1 functions to positively regulate apoptosis
and suppress cell proliferation. E2F-1 appears not to be boxº protein±protein interaction domain (Kaelin et al.,
1992; Lees et al., 1993). Therefore, any RNA transcriptscritical for entry into S phase. Rather, this function may
be served by other members of the E2F family. Taken expressed from the mutated E2F-1 locus should not
encode a functional protein. Gene-targeted J1 embry-together with previous findings demonstrating that
E2F-1 can cause oncogenesis when overexpressed, the onic stem (ES) cell lines were used to produce mice
heterozygous for the E2F-1 mutation. Heterozygotesobservations described here reveal that a single gene,
depending on its level of expression or cellular environ- (1/2) were intercrossed to generate homozygous mu-
tant mice (2/2), as demonstrated by Southern hybrid-ment, can function as either an oncogene, or paradoxi-
cally, as a suppressor of cell proliferation. ization (Figure 1B). Homozygotes produced from three
independent ES cell clones were bred into both 129/Sv
and 129/Sv 3 C57BL/6 backgrounds and gave similarResults
results in all experiments described here.
RNA expression of primary embryonic fibroblasts iso-Targeted Mutation of the E2F-1 Gene
A 7.4 kb fragment of the E2F-1 gene was used to gener- lated from wild-type and E2F-12/2 mouse embryos was
examined by Northern analysis. Fibroblasts were syn-ate a targeting vector in which the DNA binding and
dimerization domains of the E2F-1 gene were disrupted chronized at the start of S phase by exposure to hy-
droxyurea. Under these conditions, E2F-1 mRNA ex-by the insertion of a PGK-neo cassette (Figure 1A). The
site of insertion lies within a region of E2F-1 in which pression is maximal (Kaelin et al., 1992; Li et al., 1994),
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and wild-type fibroblasts express a 3.0 kb E2F-1 tran- with progenitors from thebone marrow, increased prolif-
eration of thymocytes within the thymus, failure of ma-script (Figure 1C). This transcript was not detected in
ture thymocytes to leave the thymus, or a decreasedthe E2F-12/2 fibroblasts indicating that the engineered
rate of thymocyte death.mutation successfully disrupted E2F-1 mRNA expres-
To investigate these possibilities, the developmentalsion and therefore E2F-1 function.
profiles of thymocytes from E2F-12/2 and wild-type mice
were compared. By monitoring the expression of the
E2F-1 is Not Essential for Overall
CD4 and CD8 cell surface markers, the extent of thymo-Development or Survival
cyte maturation was assessed. As thymocytes mature
E2F-12/2 mice are born and appear overtly normal. Of
they progress sequentially through double-negative
351 mice born to crosses of E2F-11/2 mice, 97 (28%)
(CD42/CD82), double-positive (CD41/CD81), and single-
were of the 1/1, 172 (49%) of the 1/2, and 82 (23%)
positive (CD41/CD82 or CD42/CD81) stages (Scollay et
of the 2/2 genotype, indicating that E2F-1 1/1, 1/2, al., 1988). Upon staining with anti-CD4 and anti-CD8
and 2/2 mice were equally viable. Moreover, crosses antibodies, thymuses of four- to six-week-old E2F-12/2
between E2F-12/2 mice also produced overtly normal mice were found consistently tocontain a higher fraction
offspring. Although E2F-12/2 mice weighed 17% less of mature thymocytes (CD41 or CD81) than wild-type
than wild-type littermates for at least the first 8 months littermates (Figure 3C). To establish further the identity
of life (p < 0.01, n 5 56 wild type, n 5 43 E2F-12/2), no of the population of thymocytes expanded in the E2F-
obvious gross or microscopic abnormalities were noted 12/2 mice, thymocytes were stained with an antibody to
in the liver, brain, gut, cardiac or skeletal muscle, bone, CD3e, a component of the T cell receptor expressed
spleen, kidneys, or pancreas at four to six weeks of age. at high levels in mature cells. The percent of CD3ehi
Thus, E2F-1 is not required for overall development, thymocytes was significantly increased in E2F-12/2
survival, or reproduction of mice. compared with wild-type mice (44% 6 12% versus 18%
Since the E2Fs are believed to play a crucial role in 6 3% ina typicalexperiment), supporting the conclusion
regulating the G1/S transition, we examined the require- that in the absence of E2F-1 the fraction of mature thy-
ment for E2F-1 in cell proliferation and cell cycle pro- mocytes is increased. Taking into account the totalnum-
gression. Surprisingly, in E2F-12/2 primary embryonic ber of thymocytes per thymus, the absolute number of
fibroblasts, the doubling time, cell cycle distribution, cells in all thymocyte populations is increased in E2F-
and timing of reentry into the cell cycle from G0 were 12/2 mice (Figure 3D). The E2F-12/2 mice exhibit a small
indistinguishable from that of wild-type fibroblasts (Fig- increase in the absolute number of immature (CD4/
ures 2A and 2B). Likewise, when lymph node cells from CD8 double-negative and double-positive) thymocytes.
four- to six-week-old E2F-12/2 mice and wild-type lit- However, E2F-12/2 mice exhibit a larger, selective in-
termates were compared, they were found to respond crease in the number of mature (CD4/CD8 single-posi-
to mitogenic signals equally well (Figure 2C). Cell pro- tive) thymocytes. Although the smaller increase in the
liferation in vivo was examined by injecting mice with number of immature thymocytes could reflect increased
5-bromo-29deoxyuridine (BrdU) to label cells in S phase. seeding of the thymus with precursor cells from the
bone marrow, the larger selective increase in the numberAs shown in Figures 2D and 2E (also Figure 5B and data
of mature thymocytes could not. In subsequent experi-not shown), proliferation ingut epithelium,spleen, lymph
ments, we focused our attention on elucidating thenodes, and thymus was indistinguishable between wild-
mechanism by which a mutation in E2F-1 leads to atype and E2F-12/2 mice at four to six weeks of age.
selective increase in the number of mature thymocytes.By contrast, in older mice differences in proliferation
A failure of thymocytes toexit the thymus and colonizebetween wild-type and E2F-12/2 mice were detected
the periphery does not account for the increase in the(see below). Nevertheless, on the basis of the findings
number of mature thymocytes in E2F-12/2 mice. First,in younger animals, we can conclude that under many
flow cytometric analysis of lymph node cells using anti-circumstances E2F-1 is not required for cell proliferation
bodies to CD3e or Thy1.2 (markers for T cells) and B220or cell cycle progression. This may reflect the ability
(a marker for B cells) revealed that, as in wild-type mice,of other E2F family members to compensate for the
the lymph nodes of E2F-12/2 mice arecomposed primar-absence of E2F-1.
ily (70% to 80%) of T cells. In addition, E2F-12/2 mice
have visibly enlarged, hypercellular lymph nodes (Figure
Thymus Abnormalities in E2F-12/2 Mice 4; p < 0.01; Student's t test, n 5 6 wild-type, n 5 6
E2F-1 was found to play a critical role in normal thymic E2F-12/2), indicating that E2F-12/2 mice also have an
development. Upon dissection, the thymuses of four- increase in the number of mature T peripheral cells.
to six-week-old E2F-12/2 mice were noticeably enlarged Thus, mature T cells effectively exit the thymus of E2F-
compared with those of 1/1 littermates, even though 12/2 mice.
other organs were consistently smaller. The ratio of thy- An increase in the rate of cell proliferation within the
mus:body weight in E2F-12/2 mice is increased by 25% thymus of young E2F-12/2mice was also ruled out as
relative to wild-type mice (Figure 3A; p < 0.03, Student's the explanation for the thymic hypertrophy observed in
t test, n 5 14 wild-type, n 5 12 E2F-12/2). The increased these animals. Thymocyte proliferation in vitro in re-
thymus size reflects a consistent increase in thymic cel- sponse to stimulation with mitogens was found to be
lularity demonstrated by a 55% increase in the number indistinguishable when thymocytes isolated from four-
of thymocytes per thymus (Figure 3B; p < 0.02, Student's to six-week-old wild-type and E2F-12/2 mice were com-
t test, n 5 10 wild-type, n 5 10 E2F-12/2). Several mecha- pared. When the cell cycle distribution of freshly har-
nisms might explain the increased number of thymo- vested thymocytes was analyzed, thymocytes from
four- to six-week-old wild-type and E2F-12/2 mice werecytes. These include increased seeding of the thymus
Cell
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Figure 2. Cell Proliferation and Cell Cycle
Distribution Are Unaltered in Young E2F-12/2
Mice
(A) Fibroblasts were harvested from wild-type
and E2F-12/2 mouse embryos and cultured
in vitro. Doubling time was measured by fol-
lowing the increase in cell number over time
as described in Experimental Procedures.
Wild-type and E2F-12/2 primary embryonic
fibroblasts had similar doublingtimes of 36.5 6
3.2 hr and 34.7 6 2.9 hr, respectively (mean 6
SEM). Error bars in this and subsequent fig-
ures indicate the SEM.
(B) The cell cycle distributions of exponen-
tially growing wild-type and E2F-12/2 primary
embryonic fibroblasts were found to be simi-
lar. To assay cell cycle distribution, 75% con-
fluent dishesof fibroblasts werepulse labeled
with BrdU for 1 hr, harvested, and fixed. DNA
content was assessed by staining with pro-
pidium iodide, and DNA synthesis assessed
by staining with an antibody to BrdU, as de-
scribed in Experimental Procedures.
(C) Lymphocytes isolated from the lymph
nodes of four- to six-week-old wild-type and
E2F-12/2 mice were stimulated in vitro with
1.5 mg/ml concanavalin A and 100 U/ml in-
terleukin-2 to assess cell cycle progression
to S phase from G0. At various times after
stimulation, cell cycle distribution was ana-
lyzed, as described in Experimental Proce-
dures. As shown, lymphocytes from wild-type
and E2F-12/2 mice responded equally well
to concanavalin A and interleukin-2. In other
experiments, other stimuli including phorbol
myristate acetate and ionomycin or staphy-
loccocal enterotoxin B and interleukin-2 were
also shown to produce similar responses
from wild-type and E2F-12/2 lymphocytes.
(D and E) In vivo BrdU labeling (as described
in Experimental Procedures) identifies cells
in S phase (appearing red) in organs from
four- to six-week-old mice. As shown, gut
epithelium (D) from four- to six-week-old
wild-type (1/1, on the left) and E2F-12/2 (on
the right) mice have similar numbers of cells
in S phase. Similarly, the spleens (E) from
four- to six-week-old wild-type (1/1, on the
left) andE2F-12/2 (on the right) mice also have
similar numbers of cells in S phase.
found to have similar cell cycle distributions (Figure 5A). Apoptosis was initially examined by monitoring the per-
cent viability of in vitro cultured wild-type and E2F-12/2To examine in vivo the fraction of cells in S phase in the
thymuses of wild-type and E2F-12/2 mice, four- to six- thymocytes. Only 40% of wild-type thymocytes were
still viable after one day in culture. Control experimentsweek-old mice were injected with BrdU. Wild-type thy-
muses, as expected, demonstrated labeling predomi- demonstrated this loss of viability to be via an apoptotic
pathway as measured by DNA end labeling techniques.nantly of cells of the thymic cortex (Figure 5B), indicating
proliferation of immature thymocytes. E2F-12/2 thy- Bycontrast, thymocytes from E2F-12/2 littermatesmain-
tained 60% viability over the same time period, an in-muses demonstrated a similar distribution and extent
of labeling. Together, these experiments indicate that crease of 50% over wild-type (Figure 6A). In seven inde-
pendent experiments comparing a total of 13 wild-typethymocyte proliferation both in vitro and in vivo in four-
to six-week-old mice is not affected by the absence and 13 E2F-12/2 littermates four to six weeks of age,
the E2F-12/2 thymocytes consistently show increasedof E2F-1.
On the other hand, our analysis revealed a clear differ- viability. This increase in the survival of thymocytes from
E2F-12/2 mice is statistically highly significant (p < 0.001,ence in the extent of apoptotic cell death when thymo-
cytes from wild-type and E2F-12/2 mice were compared. two-way [genotype and days in culture] analysis of vari-
Apoptosis and Proliferation in E2F-1 Deficient Mice
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Figure 3. E2F-12/2 Mice Have an Excess
Number of Mature Thymocytes and T Cells
(A) The weights of the thymuses from 14 wild-
type and 12 E2F-12/2 mice four to six weeks
of age are expressed as fraction of total body
weight. As shown, relative thymus size of
E2F-12/2 mice is 25% greater than their wild-
type littermates. For comparison, liver weight
as a fraction of total body weight is 7% less
for E2F-12/2 mice than their wild-type lit-
termates (data not shown). The increase in
size of the thymuses in E2F-12/2 mice com-
pared with wild-type is statistically signifi-
cant, with p < 0.03 (Student's t test).
(B) Thymocytes were harvested from the thy-
muses of 10 wild-type and 10 E2F-12/2 mice.
The number of thymocytes per thymus was
counted and is shown in the graph. E2F-12/2
mice show a 55% increase in the number of
thymocytes per thymus compared with wild-
type littermates (mean 6 SEM for wild
type 5 99 6 11 3 106 cells per thymus, for
E2F-12/2 5154 6 18 3 106 cells per thymus).
The effect of genotype on number of thymo-
cytes per thymus is statistically significant,
with p < 0.02 (Student's t test).
(C) Thymocyte expression of the CD4 and
CD8 cell surface antigens was examined by
flow cytometry. Thymocytes from wild-type
and E2F-12/2 mice were labeled with a fluo-
rescein conjugated antibody to CD8 and an
R-phycoerythrin conjugatedantibody to CD4.
CD4 and CD8 expression per cell were ana-
lyzed by flow cytometry. In the graphs shown,
each dot indicates the CD4 and CD8 expres-
sion levels for a single cell. The cell popula-
tions are divided into quadrants representing
CD4/CD8 double-negative (lower left), CD4/
CD8 double-positive (upper right), CD4 sin-
gle-positive (upper left), and CD8 single-posi-
tive (lower right) populations. The numbers in
each quadrant represent the percentage of
cells in that quadrant (mean 6 SEM). As
shown, the more mature CD4 and CD8 single-
positive populations are expanded in the
E2F-12/2 mice. The experiment shown repre-
sents duplicate measurements from one pair
of mice and is representative of seven experi-
ments comparing in total 13 wild-type to 13
E2F-12/2 mice.
(D) Calculation of the absolute number of thy-
mocytes in each subpopulation based on the
percentages measured in (C) and the total
number of cells per thymus for each animal.
E2F-12/2 mice have a small increase in the
absolute number of CD4/CD8 double-nega-
tive and double-positive thymocytes com-
pared to wild-type. However, E2F-12/2 mice
have a larger selective increase in the abso-
lute number of CD4/CD8 single-positive thy-
mocytes compared with wild-type.
ance [ANOVA] of thymocyte viability, n 5 13 wild-type, homogeneous subpopulations of wild-type and E2F-12/2
thymocytes. CD4/CD8 double-positive or single-posi-n 5 13 E2F-12/2). In an average thymus, an increase in
survival of this magnitude would represent the inappro- tive thymocytes from wild-type or E2F-12/2 mice were
purified by cell sorting, and their survival in culture waspriate survival of over 30 million cells per day.
Since the thymocyte population in E2F-12/2 mice dif- assayed. Purified CD41/CD81 thymocytes from E2F-
12/2 mice displayed a clearly enhanced level of survivalfered from that of wild-type mice in that it includes a
higher proportion of mature cells, a clear demonstration in culture when compared with their wild-type counter-
parts (Figure 6B), confirming a defect in apoptosis inof a defect in apoptosis in the E2F-12/2 thymocytes re-
quired a comparison of the survival of developmentally the E2F-1 deficient thymocytes. By contrast, the survival
Cell
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Figure 4. E2F-12/2 Mice Have Enlarged Hypercellular Lymph Nodes
Lymph nodes from E2F-12/2 mice compared with lymph nodes from
corresponding anatomical locations from wild-type littermates are
visibly enlarged (data not shown). To count the number of cells per
lymph node, 12 or 13 lymph nodes were harvested from each of
six E2F-12/2 mice and six wild-type littermates from corresponding
anatomical locations (generally, two from external abdominal fascia,
six axillary, four submandibular, and one from the ilial bifurcation
of the abdominal aorta). Cells were harvested from the lymph nodes,
counted, and the average number of cells per lymph node calcu-
lated. The E2F-12/2 mice had 2.3 6 0.2 3 106 cells per lymph node,
Figure 5. Thymocyte Proliferation Is Not Detectably Altered inwhile wild-type littermates had 1.5 6 0.2 3 106 cells per lymph node
Young E2F-12/2 Mice(mean 6 SEM). The increased number of cells per lymph node in
E2F-12/2 mice relative to wild-type littermates is statistically signifi- (A) Thymocytes were harvested from wild-type and E2F-12/2 mice
cant with p < 0.01 (Student's t test). four to six weeks of age and immediately pulse labeled for 1 hr
with 10 mM BrdU. Cells were fixed and cell cycle distribution was
measured as described in Experimental Procedures. As shown,of the more mature single-positive thymocytes was un-
freshly isolated thymocytes from young wild-type andE2F-12/2 miceaffected by the loss of E2F-1 (Figure 6C). Like the mature
are similarly distributed through the cell cycle.
thymocytes, the lymph node cells from E2F-12/2 and
(B) In vivo BrdU labeling (as described in Experimental Procedures)wild-type mice, which are primarily mature single-posi-
identifies thymocytes in S phase (appearing red) in thymuses from
tive T cells, also displayed comparable viability. We con- four- to six-week-old wild-type and E2F-12/2 mice. As shown, young
clude that the less mature double-positive E2F-12/2 thy- wild-type and E2F-12/2 mice have similar numbers of cells in S
mocytes exhibit a stage-specific defect in apoptosis. phase in the thymus in vivo.
The observation that CD41/CD81 thymocytes from
E2F-1 deficient mice are not as susceptible to apoptosis
as wild-type thymocytes raises the possibility that the thymocyte apoptosis both in vitro and in vivo. Moreover,
mutant thymocytes might be defective in the process E2F-12/2 thymocytes demonstrate a defect in T cell re-
of negative selection. Negative selection, the mecha- ceptor±stimulated apoptosis in vivo, as might be ex-
nism by which thymocytes that recognize self-antigen pected if there is a defect in negative selection in these
are eliminated, results from apoptotic loss of self-anti- mice. The defect inCD4/CD8 double-positive thymocyte
gen-recognizing thymocytes stimulated through the T apoptosis in E2F-12/2 mice is likely the cause of the
cell receptor. To investigate the possibility that E2F-1 increased production of single-positive thymocytes and
might play a role in immunologic negative selection, T T cells in these animals and probably accounts for the
cell receptor signalling was stimulated in E2F-12/2 and thymic and lymph node hypertrophy observed in the
wild-type mice by the injection of anti-CD3e antibodies
E2F-12/2 mice. We conclude that a primary function of
and the effect on thymic apoptosis analyzed. This stimu-
E2F-1 invivo is to regulate apoptosis in immature thymo-
lus triggers apoptosis primarily in CD41/CD81 thymo-
cytes.cytes by a mechanism that may mimicnegative selection
(Owen et al., 1988; Smith et al., 1989; Shi et al., 1991).
Mice were injected with anti-CD3e or control vehicle,
Effects of E2F-1 Loss in Older Miceand 16 hr later the fraction of cells undergoing apoptosis
We next considered the possibility that the decreasedwas determined using an in situ single cellDNA fragmen-
apoptosis in the CD41/CD81 thymocytes of young E2F-tation assay. As expected the injection of anti-CD3e
12/2 mice and/or the continued absence of E2F-1 inantibodies into wild-type mice led to a significant in-
these animals might affect the function of the thymuscrease (3- to6-fold) in thymocyte apoptosis. By contrast,
or other organs in older E2F-12/2 mice. To examine thethymocytes of E2F-12/2 mice exhibited significantly less
effect of the E2F-1 mutation in older mice, wild-type and(50%) anti-CD3e-induced thymocyte apoptosis (Figure
E2F-12/2 mice 6 to 12 months of age were compared7; p < 0.002, paired t test, n 5 5 wild-type, n 5 5 E2F-
12/2). Thus, E2F-12/2 mice display a defect in CD41/CD81 in a variety of ways. Both the gross and microscopic
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morphology of liver, gut, brain, cardiac and skeletalmus-
cle, spleen, bone, and kidney were found to be similar
in wild-type and E2F-12/2 mice. However, older E2F-
12/2 mice displayed moderate testicular atrophy (z60%
reduction in weight, data not shown). The reduction in
testicular weight seems to result from a decrease in the
number of sperm found in many of the seminiferous
tubules. Furthermore, these same tubules are observed
to contain an overgrowth of interstitial Leydig cells.
While the mechanism of testicular atrophy is uncertain,
it is possible that an overgrowth of Leydig cells is the
cause of decreased sperm production, and thus the
decrease in testicular weight.
The most dramatic finding in the older E2F-12/2 mice
was again in the thymus. Examination of cellproliferation
in 10 wild-type and 11 E2F-12/2 mice by in vivo labeling
with BrdU revealed a striking increase in proliferation in
the thymus of older E2F-12/2 mice compared with wild-
type littermates (Figure 8A). The proliferating cells in
most of these E2F-12/2 mice maintained normal mor-
phology and were localized to the thymic cortex but
not the medulla. The localization of these proliferating
thymocytes within the cortex suggests that they are
likely to be immature thymocytes. The large increase in
the number of proliferating cells in the thymic cortex of
older E2F-12/2 mice was seen in all 11 E2F-12/2 thy-
muses examined, indicating a role for E2F-1 in the con-
trol of thymocyte proliferation in older mice. Other tis-
sues, including gut epithelium, spleen, lymph nodes,
and liver in the E2F-12/2 mice displayed BrdU labeling
indices that were comparable to those seen in wild-type
mice (Figure 8B). One of the 11 older E2F-12/2 animals,
in addition to displaying increased thymic proliferation,
Figure 6. CD4/CD8 Double-Positive Thymocytes from E2F-12/2
Mice Exhibit a Maturation Stage±Specific Defect in Apoptosis In
Vitro
(A) Thymocytes harvested from wild-type and E2F-12/2 mice were
cultured in vitro for various amounts of time. Cell viability was as-
sayed by trypan blue exclusion. Loss of viability was through
apoptosis as demonstrated by early DNA fragmentation measured
using in situ nick translation (data not shown). The data shown
represent the mean 6 SEM for quadruplicate measurements of via-
bility of cultures from two wild-type and two E2F-12/2 mice after 24
hr in vitro and are graphed as viability relative to one of the wild-
type controls. These data are representative of experiments com-
paring, in total, thymocytes from 13 wild-type and 13 E2F-12/2 mice.
The difference in survival of thymocytes from wild-type and E2F-
12/2 mice is statistically significant with p < 0.001 (two-way ANOVA
of thymocyte viability grouped by genotype and days in culture).
(B) and (C) CD4/CD8 double-positive (B) and single-positive (C) thy-
mocytes were purified by fluorescence-activated cell sorting after
labeling with fluorescein isothiocyanate±conjugated anti-CD8 and
R-phycoerythrin-conjugated anti-CD4. Cell viability over time was
assayed by trypan blue exclusion. The data shown represent the
mean 6 SEM for duplicate measurements at each time point for
thymocytes from each animal. All thymocyte cultures had >95%
viability at the start of the experiment. These data are representative
of experiments comparing, in total, thymocytes from 4 wild-type
and 3 E2F-12/2 mice. The difference between the rates of apoptosis
of wild-type and E2F-12/2 double-positive, but not single-positive,
thymocytes was corroborated by comparing the survival of thymo-
cytes (predominantly double-positive cells) and lymph node cells
(predominantly single-positive T cells) from two mice of each geno-
type (data not shown).
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E2F-1 are in many ways normal. E2F-12/2 mice undergo
normal embryonic development, are fully viable at birth,
and mature to become reproductively competent. The
ability of E2F-12/2 mice to do so well may be indicative
of the ability of other E2F family members to provide
sufficient E2F function for most developmental path-
ways. Nevertheless, further examination of the E2F-12/2
mice has led to the identification of important nonredun-
dant functions of E2F-1.
Most notably, within one month of birth E2F-12/2 mice
display visible enlargement of the thymus and lymph
nodes despite a reduction in the size of other organs.
These enlarged lymphoid organs reflect an expansion
of the population of mature CD4/CD8 single-positive
thymocytes and peripheral T cells. This expansion ap-
pears to be due to a defect in a normal pathway of
apoptosis. The defect in CD41/CD81 thymocyte apop-
tosis in E2F-12/2 mice is observed in every animal exam-
ined, indicating a consistent and important role for
Figure 7. E2F-12/2 Mice Display a Defect in Thymocyte Apoptosis E2F-1 in thymocyte apoptosis.
In Vivo Apoptosis has been previously shown to be an impor-
T cell receptor±mediated thymocyte apoptosis was stimulated by tant event duringnormal thymocyte maturation. Notably,
injecting four- to six-week-old mice with an activating antibody to the elimination of thymocytes bearing self-reactive T
CD3e (2C11) and assaying apoptosis 16 hr later using a DNA end± cell receptors occurs during negative selection and is
labeling method (TUNEL; Gavrieliet al., 1992) as described in Experi-
believed to be mediated by T cell receptor±stimulatedmental Procedures. The figure depicts pooled data from four
apoptosis of CD4/CD8 double-positive thymocytes justindependent experiments comparing in total five wild-type and five
prior to their conversion into mature thymocytes (Fowl-E2F-12/2 mice injected with anti-CD3e. The reduction in anti-CD3e-
induced apoptosis seen in E2F-12/2 mice compared with wild-type kes et al., 1988; Kisielow and von Boehmer, 1991). These
is statistically significant with p < 0.002 (paired t test). Negative observations, taken together with our finding that E2F-
controls omitting terminal deoxynucleotidyl transferase showed 12/2 mice have a defect in T cell receptor±stimulated
background staining of 0.6% 6 0.1%. Positive controls treated with
apoptosis of CD4/CD8 double-positive thymocytes,DNaseI showed 41% 6 9% staining, and 33% 6 3% of thymocytes
raise the possibility that E2F-1 may play an importanttreated with dexamethasone were apoptotic.
role in the process of negative selection.
As E2F-12/2 mice age, a second phenotype, charac-
also contained a region of the thymus with altered mor- terized by a dramatic increase in thymocyte prolifera-
phology indicative of a lymphoblastic lymphoma (Figure tion, is observed. This aberrant hyperproliferation oc-
8C). In vivo labeling of this animal with BrdU demon- curs in the thymic cortex, but not thymic medulla or
strated that cells within the tumor were rapidly proliferat- lymph nodes, suggesting that it is due to the presence
ing. None of the 10 wild-type littermates that were exam- of proliferating immature thymocytes. The finding that
ined contained detectable tumors. More extensive the disruption of E2F-1 function leads to increased thy-
analysis of older mice by Yamasaki et al. (1996 [this mocyte proliferation implies that E2F-1 normally func-
issue of Cell]) has revealed sporadic tumorigenesis in a tions as a suppressor of cell proliferation.
wide variety of tissues in E2F-12/2 animals, suggesting The fact that the decreased apoptosis detected in
that our detection of a tumor in one of the 11 older young mice and the increased cell proliferation seen in
animals that we have sacrificed may reflect a real in- older mice both were observed in the thymus suggests
crease in the rate of tumorigenesis in these mice. Con- that the two phenotypes may be mechanistically related.
sistent with this possibility, we have found that as our For example, inactivation of E2F-1's apoptotic function
E2F-12/2 mice age they die at a significantly higher rate may lead indirectly to the hyperproliferation of immature
than their wild-type littermates. Although for many the thymocytes. Thus, the role proposed here for E2F-1 may
cause of death remains to be elucidated, preliminary be analogous to that of the p53 tumor suppressor gene.
evidence suggests that a number of these mice had p53 is believed to play a critical role in suppressing
tumors. What we can conclude from our experiments inappropriate cell proliferation. In cells that have under-
is that as E2F-12/2 mice age they exhibit a consistent gone a mutation that leads to their aberrant proliferation,
phenotype of thymic hyperproliferation that at least in p53 somehow triggers cell death. In the absence of p53,
one case resulted in the formation of a lymphoblastic for example in the cells of p53-deficient animals, these
lymphoma. Together, these findings indicate that inappropriately proliferating cells do not die. Rather,
E2F-1 functions in vivo as a suppressor of cell prolifer- they expand in number and can give rise to tumors.
ation. Similarly, the observed failure of immature thymocytes in
E2F-12/2 mice toundergo normallyscheduled apoptosis
Discussion may result in the survival of an excessive number of
proliferating thymocytes as is observed in older E2F-
To investigate the functions of E2F-1, we generated 12/2 mice. Interestingly, this suggests that E2F-1 may
play a direct role in regulating apoptosis independentE2F-1 deficient mice. Surprisingly, mice deficient in
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Figure 8. Older E2F-12/2 Mice Display Thy-
mic Hyperproliferation and Tumorigenesis
Wild-type and E2F-12/2 mice 6 to 12 months
of age were injected with BrdU to label cells
in S phase. Organs were harvested 4 hr later
and stained to identify BrdU-incorporating
cells (stained red) as described in Experimen-
tal Procedures. Asshown in (A), wild-type thy-
muses (1/1, right) had few cells in S phase,
while E2F-12/2 thymuses (left) had many cells
in S phase. In contrast, other organs, includ-
ing gut epithelium, as shown in (B), had simi-
lar numbers of cells in S phase in wild-type
(1/1, right) and E2F-12/2 (left) mice. In 1 of
11 older E2F-12/2 mice a tumor was present,
as shown in (C). Tumor tissue is present on
the left side of this photograph, while normal
thymus is seen on the right. The tumor is iden-
tified as a lymphoblastic lymphoma on the
basis of standard pathologic criteria includ-
ing monotony of cell morphology, nucleus
size, dispersed chromatin pattern, and scant
cytoplasm. Cells of this tumor are rapidly pro-
liferating as demonstrated by the high frac-
tion of BrdU-labeled cells (labeling index
of 41%).
of its function as a regulator of cell proliferation. Several sites during G0 or G1. This might lead to aberrant ex-
pression of particular cell cycle regulatory genes andrecent findings provide support for this possibility. First,
we find that the thymuses of young E2F-12/2 mice exhibit inappropriate cell proliferation. A role for E2F-1 in the
suppression of thymocyte cell cycle progression mighta defect in apoptosis in the absence of any measurable
change in cell cycle distribution. Second, in a recent explain the aberrant hyperproliferation seen in the thy-
mus of older E2F-12/2 mice.mutagenesis study E2F-1's roles as a regulator of
apoptosis and cell cycle progression were found to be If E2F-1 functions primarily as a suppressor of cell
cycle progression, then the defect in apoptosis seen inseparable (Krek et al., 1995).
Nevertheless, it remains a possibility that E2F-1 func- young E2F-12/2 mice could be an indirect consequence
of a defect in cell cycle progression. Although we de-tions primarily as a suppressor of cell proliferation. Con-
sistent with this possibility is the observation that E2F tected no change in the cell cycle distribution of thymo-
cytes in young E2F-12/2 mice, we cannot exclude theDNA binding sites in the promoters of several cell cycle
genes function primarily to repress transcriptionof these possibility that there is a subtle increase in proliferation
or progression through the cell cycle in the E2F-12/2genes during G0 and G1 (Weintraub et al., 1992, 1995;
Neuman et al., 1995), presumably by binding E2F-Rb cells. If it is necessary that a thymocyte be in a particular
phase of the cell cycle to engage apoptosis, a changecomplexes. Recent data suggest that by repressing
transcription E2F-1±Rb complexes suppress entry into in cell cycle distribution caused by the mutation of
E2F-1 might lead indirectly to a decrease in apoptosis.S phase (Sellers et al., 1995). Thus, an E2F-1 deficient
cell may be unable to tether Rb to E2F-1 DNA binding A direct role for E2F-1 in either apoptosis or as a
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hybridization probe was prepared from a 0.9 kb SalI±EcoRI fragmentsuppressor of cell cycle progression may explain addi-
of the human E2F-1 cDNA plasmid pSP72-RBAP-1 (Kaelin et al.,tional phenotypes that we and Yamasaki et al. (1996)
1992) and labeled by random priming. DNA was isolated from puri-observe in the E2F-12/2 mice such as testicular atrophy,
fied positives and a 7.4 kb fragment spanning the bulk of the
increased mortality, and sporadic tumor formation. For E2F-1 gene was subcloned into pBlueScript KS(1) from two inde-
example, the overgrowth of interstitial Leydig cells in pendent l clones. Further restriction mapping, Southern hybridiza-
the testes may be due to a failure of these cells to tion, and DNA sequencing suggested that these two fragments were
identical and represented the bona fide E2F-1 gene. To generate aundergo apoptosis or growth arrest. Similarly, sporadic
gene targeting vector, a fragment containing PGK-neo was insertedtumors in the E2F-12/2 mice might be the result of a
by blunt-end ligation into the XcmI site in exon 3 of E2F-1 and adefect in apoptosis or growth suppression in these cells.
1.7 kb SmaI/EcoRV fragment containing E2F-1 exon 4 was excised.Although in the thymus E2F-1 plays a consistent role
The disrupted E2F-1 genomic fragment was then inserted into a
in preventing abnormal cell proliferation, the sporadic backbone containing a PGK-TK gene to provide a negative se-
nature of the abnormal proliferation seen in other cell lectable marker (Tybulewicz et al., 1991).
types suggests that in these cell types random muta-
tions may be required to unmask E2F-1's role in growth
Embryonic Stem Cell Culture and Embryo Manipulation
suppression. J1 ES cell culture, electroporation, and selection of subclones were
The phenotype of the E2F-12/2 mice is surprising performed essentially as described (Li et al., 1992). Injection of ES
given the widely held view that E2Fs function primarily cells into host blastocysts and their surgical introduction into foster
mothers were performed essentially as described (Robertson, 1987).as positive regulators of cell cycle progression and that
E2F-1 overexpression can cause oncogenesis. Our data
does not support a unique role for E2F-1 as a promoter Southern Hybridization and Northern Hybridization
of cell proliferation. Rather, we find that E2F-1 plays a DNA isolated (Laird et al., 1991) from the offspring of chimeras
and subsequent generations was digested with EcoRV (or othercritical role as a positive regulator of apoptosis and a
restriction enzymes) and used in standard Southern blots (Churchsuppressor of cell proliferation. How can these roles be
and Gilbert, 1984) using a probe prepared from E2F-1 genomicreconciled with the observed ability of E2F-1 to drive
sequences to determine the genotypes of the mice.cell cycle progression and oncogenesis when overex-
For Northern hybridization, embryonic fibroblasts were isolated
pressed? It is likely that the level of E2F-1 expression by standard methods (Robertson, 1987), grown to 75% confluence,
is important. Under normal circumstances, in G0 and and arrested in early S phase by treatment with 100 mM hydroxyurea
G1 E2F-1 may be completely bound up by Rb so that for 16 hr. RNA was isolated (Chomczynski and Sacchi, 1987) and
used in standard Northern hybridization (Church and Gilbert, 1984)it functions primarily as a repressor of transcription and
using a probe prepared from a 0.9 kb SalI±EcoRI fragment of thea suppressor of cell proliferation. When E2F-1 is overex-
human E2F-1 cDNA (Kaelin et al., 1992) or a 1.3 kb probe preparedpressed there may not be sufficient Rb present in the
from a PstI restriction fragment of the rat glyceraldehyde-3-phos-cell to bind up all the E2F-1. Under such a circumstance,
phate dehydrogenase cDNA (Fort et al., 1985).
free E2F would be present and might be capable of
promoting inappropriate entry into S phase and ulti-
Isolation of Primary Embryonic Fibroblastsmately oncogenesis. Since under normal circumstances
and Measurement of GrowthE2F-1 may have a dual role as a supressorof cell prolifer-
Primary embryonic fibroblasts were harvested from 13.5- or 14.5-
ation in G0/G1 and an activator of proliferation in G1/S, day-old embryos using the protocol of Robertson (1987) with minor
the effect of a mutation in E2F-1 might be difficult to modifications. Doubling times were measured by plating fibroblasts
predict. The fact that a deletion of E2F-1 leads to a on multipledishes, trypsinizing, and countingcell numbers on paired
dishes after one, two, or three days of culture. Doubling time wasdecrease in apoptosis and enhanced proliferation sug-
calculated from the slope of the best fit line of logarithm of cellgests that in vivo the negative effects of E2F-1 on cell
number as a function of time. Data were pooled from multipleexperi-cycle progression may be more important than the posi-
ments comparing in total fibroblasts independently isolated fromtive effects. Nevertheless, the fact that E2F-1 is a mem-
four wild-type and four E2F-12/2 mouse embryos.
ber of a large family of related genes leaves open the
possibility that E2F-1 also plays an important role in
Harvest of Thymocytes and Lymph Node Cellspromoting S phase entry in many cell types but that in
Thymuses or lymph nodes were mechanically dissociated betweenits absence this role is compensated for by other family
two pieces of ground glass. Debris was allowed to settle, the cells
members. washed in medium (Iscove's modified Dulbecco's medium), and
A more thorough understanding of the multiple over- contaminating erythrocytes removed by hypotonic lysis (155 mM
lapping functions of different E2F family members must NH4Cl/10 mM KHCO3/0.1 mM EDTA [pH 7.3] on ice for 5 min). The
cells were washed again in medium and then used in subsequentawait the production of mice containing mutations of
experiments.other E2F family members, either singly or in combina-
tion. Nevertheless, the generation of E2F-1 deficient
mice is a start in this direction and has provided new Cell Cycle Analysis
Cells were pulse labeled with 10 mM BrdU for 1 hr, washed in ice-insight into the function of the E2F family. Somewhat
cold phosphate-buffered saline (PBS), and fixed in ice-cold 70%unexpectedly the analysis of this animal, taken together
ethanol. One to ten days later, cells were processed for flow cytome-with previous studies, has revealed that a single gene,
tric analysis of DNA content (staining with propidium iodide) anddepending on the circumstance, can function both as
DNA synthesis (staining with fluorescein isothiocyanate±conjugated
an oncogene and as a growth suppressor gene. antibody to BrdU) according to a protocol from the supplier of the
antibody (Becton-Dickinson).
Experimental Procedures
In Vivo S Phase LabelingCloning
Mice were injected intraperitoneally with BrdU in PBS at a dose ofA murine E2F-1 genomic clone was isolated from a 129/Sv genomic
50 mg per gram of body weight. Mice were sacrificed 4 hr later, andlibrary in lFIXII (Stratagene) screened by hybridization using Gene-
Screen (NEN) according to the instructions of the manufacturer. The organs harvested and fixed in 10% formalin. Slides of tissue sections
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were stained with antibody to BrdU and processed using the Vecta- Blake, M.C., and Azizkhan, J.C. (1989). Transcription factor E2F is
required for efficient expression of the hamster dihydrofolate reduc-Stain ABC alkaline phosphatase immunostaining kit (Vector Labora-
tories) according to the instructions of the manufacturer. Sections tase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994±5002.
were counterstained with hematoxylin. Cao, L., Faha, B., Dembski, M., Tsai, L.H., Harlow, E., and Dyson,
N. (1992). Independent binding of the retinoblastoma protein and
Flow Cytometry and Fluorescence-Activated Cell Sorting p107 to the transcription factor E2F. Nature 355, 176±179.
Cells were suspended in blocking buffer (3% fetal bovine serum, Chellappan, S.P., Hiebert, S., Mudryj, M.,Horowitz, J.M., and Nevins,
1% bovine serum albumin in PBS) and mixed with a fluorescein J.R. (1991). The E2F transcription factor is a cellular target for the
isothiocyanate±conjugated antibody (either anti-CD8 [clone 53-6.7], RB protein. Cell 65, 1053±1061.
anti-CD3e [clone 145-2C11], or anti-Thy1.2 [clone 30-H12]) and an
Chittenden, T., Livingston, D.M., and Kaelin, W.G., Jr. (1991). TheR-phycoerythrin-conjugated antibody (either anti-CD4 [clone
T/E1A-binding domain of the retinoblastoma product can interactH129.19], anti-CD8 [clone 53±6.7], or anti-B220 [clone RA3±6B2], all
selectively with a sequence-specific DNA-binding protein. Cell 65,purchased from Pharmingen). After 15 min, labeled cells were
1073±1082.washed twice in blocking buffer, once in PBS, and fixed in fresh
Chomczynski, C., and Sacchi, N. (1987). Single-step method of RNA1% paraformaldehyde in PBS for flow cytometry or resuspended in
isolation by acid guanidinium thiocyanate-phenol-chloroform ex-medium for fluorescence-activated cell sorting. Appropriate single
traction. Anal. Biochem. 162, 156±159.color controls were used to set flow cytometer compensation and
quadrants. Church, G.M., and Gilbert, W. (1984). Genomic sequencing. Proc.
Natl. Acad. Sci. USA 81, 1991±1995.
In Vitro Apoptosis Cobrinik, D., Whyte, P., Peeper, D.S., Jacks, T., and Weinberg, R.A.
Thymocytes or lymph node cells were plated in 96-well plates at a (1993). Cell cycle-specific association of E2F with the p130 E1A-
concentration of 5 3 105 cellsper 100 ml in Iscove's modified Dulbec- binding protein. Genes Dev. 7, 2392±2404.
co's medium supplemented with 10% heat-inactivated fetal bovine Cress, W.D., Johnson,D.G., and Nevins, J.R. (1993). Agenetic analy-
serum, 0.5 mM b-mercaptoethanol, and 1 mM HEPES (pH 7.4). Im- sis of the E2F1 gene distinguishes regulation by Rb, p107, and
mediately after plating, or at various time intervals, aliquots from adenovirus E4. Mol. Cell. Biol. 13, 6314±6325.
replicate wells were mixed with an equal volume of 0.4% trypan
DeGregori, J., Kowalik, T., and Nevins, J.R. (1995). Cellular targetsblue, and the concentrations of live and dead cells counted on a
for activation by the E2F1 transcription factor include DNA synthe-hemacytometer. In situ nick translation performed by the method
sis- and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215±4224.of Gold et al. (1993) was used to verify that DNA fragmentation was
Devoto, S.H., Mudryj, M., Pines, J., Hunter, T., and Nevins, J.R.an early event in cell death.
(1992). A cyclin A±protein kinase complex possesses sequence-
specific DNA binding activity: p33cdk2 is a component of the E2F±In Vivo Apoptosis
cyclin A complex. Cell 68, 167±176.Antibody to CD3e (clone 145±2C11, no azide, low endotoxin formula-
tion, purchased from Pharmingen) diluted in PBS was injected intra- Dou, Q.P., Markell, P.J., and Pardee, A.B. (1992). Thymidine kinase
peritoneally at a dose of 1.9 to 2.5 mg per gram body weight (in a transcription is regulated at G1/S phase by a complex that contains
given experiment all mice were injected at the same dose). Control retinoblastoma-like protein and a cdc2 kinase. Proc. Natl. Acad. Sci.
mice were injected with a similar volume (0.2 ml) of PBS. Thymocytes USA 89, 3256±3260.
were isolated 16 hr later and processed for TUNEL (Gavrieli et al., Duronio, R.J., and O'Farrell, P.H. (1995). Developmental control of
1992) according to the instructions for the fluorescein Apoptag kit the G1 to S transition in Drosophila: cyclin Eis a limiting downstream
(Oncor). Compensation and gates for flow cytometry were set using target of E2F. Genes Dev. 9, 1456±1468.
appropriate controls. For negative controls TUNEL was performed
Duronio, R.J., O'Farrell, P.H., Xie, J.E., Brook, A., and Dyson, N.
omitting the terminal deoxynucleotidyl transferase. As positive con-
(1995). The transcription factor E2F is required for S phase during
trols, thymocytes were treated with 1 mM dexamethasone for 4 hr
Drosophila embryogenesis. Genes Dev. 9, 1445±1455.
in vitro, or fixed thymocytes were treated with DNaseI.
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